Response to the proposed advice for health and social care practitioners involved in looking after people in the last days of life

Similar documents
All-Party Parliamentary Group on Motor Neurone Disease

Tribute Funds. Create a lasting. celebration. of your loved one

Dudley End of Life and Palliative Care Strategy Implementation Plan 2017

National Dementia Policy in England Responding to the Prime Ministers Challenge

Ensuring that dying patients and their families receive good End of Life Care

CANDIDATE PACK. Trustee

DEMENTIA. Best Practice Guidance for Ambulance Services

ROLE SPECIFICATION FOR MACMILLAN GPs

National Dementia Vision for Wales Dementia Supportive Communities

PROMOTING HUMAN ORGAN DONATION AND TRANSPLANTATION IN NORTHERN IRELAND. Consultation Proposals & Response Questionnaire

POLICY BRIEFING. Prime Minister s challenge on dementia 2020 implementation plan

Local Healthwatch Quality Statements. February 2016

MEAM Approach network communications guide

Palliative and end of life care Priority Setting Partnership

Palliative Care Asking the questions that matter to me

Low back pain and sciatica in over 16s NICE quality standard

Patient and Carer Network. Work Plan

Greater Manchester Health and Care Board

Dementia Action Alliance survey for carers and professionals

HERTS VALLEYS CCG PALLIATIVE AND END OF LIFE CARE STRATEGY FOR ADULTS AND CHILDREN

Dr David Geddes. Head of Primary Care Commissioning. LDC Officials Day. 6 December 2013

A future where everybody who develops breast cancer lives and lives well. Our vision, mission, values and five-year strategy ( )

PRIMARY CARE CO-COMMISSIONING COMMITTEE 8 SEPTEMBER 2015

What happens if I cannot make decisions about my care and treatment?

The role of cancer networks in the new NHS

Legal. Advance Directives. About this factsheet. Factsheet Leg 8 October of 12

Dementia Strategy MICB4336

Think Piece. Dementia 2014: A North East Perspective

NAS NATIONAL AUDIT OF SCHIZOPHRENIA. Second National Audit of Schizophrenia What you need to know

Directed Enhanced Service (DES) for H1N1 Vaccination Programme JCVI priority groups

Alzheimer s Society. Consultation response. Our NHS care objectives: A draft mandate to the NHS Commissioning Board.

Number of people with diabetes

The Road Ahead Strategy

Our Strategy

The Ayrshire Hospice

The Way Ahead Our Three Year Strategic Plan EVERY MOMENT MATTERS

Compare your care. How asthma care in England matches up to standards R E S P I R AT O R Y S O C I E T Y U K

The Palliative and end of life care Priority Setting Partnership with the James Lind Alliance (PeolcPSP)

MCIP Recruitment Pack

You said we did. Our Healthier South East London. Dedicated engagement events

Invitation to Tender

Living Well With Dementia in North Yorkshire. Summary

Professional Development: proposals for assuring the continuing fitness to practise of osteopaths. draft Peer Discussion Review Guidelines

Discussion Document - National Health and Social Care Workforce Plan

Evaluation of the Type 1 Diabetes Priority Setting Partnership

Dementia Priority Setting Partnership. PROTOCOL March 2012

Kirklees Safeguarding Children Board. Annual Report. January 2011 March Executive Summary.

SERVICE SPECIFICATION 6 Conservative Management & End of Life Care

Your Voices Amplified

Talking to someone who might be suicidal

End of life care for people with Dementia

Northamptonshire Hospice Charities Strategy

ongoing development of governance and leadership to support improvement ongoing national roll out of the electronic palliative care summary (epcs)

Volunteer Satisfaction Survey

National Cancer Programme: Living With and Beyond Cancer. Becky Clack Programme Manager, NHS England. September

Polypharmacy and Deprescribing. A special report on views from the PrescQIPP landscape review

Model the social work role, set expectations for others and contribute to the public face of the organisation.

Consent to research. A draft for consultation

Yorkshire and the Humber Strategic Clinical Networks

Speaking on the day of publication, John Milne, Chair of the BDA s General Dental Practice Committee, said:

SUBMISSION FROM THE NATIONAL AUTISTIC SOCIETY SCOTLAND

Collation of responses to GW. 1. Please state the definitions that you use for different forms of palliative and end of life services

Putting NICE guidance into practice. Resource impact report: Hearing loss in adults: assessment and management (NG98)

Deciding whether a person has the capacity to make a decision the Mental Capacity Act 2005

Dementia Programme Kevin Mullins Head of Mental Health Services

Deciding whether to get screened for an abdominal aortic aneurysm (AAA)

Shared Decision Making screening for abdominal aortic aneurysm. Deciding whether to get screened for an abdominal aortic aneurysm (AAA)

Managing conversations around mental health. Blue Light Programme mind.org.uk/bluelight

WELSH GOVERNMENT RESPONSE TO RECOMMENDATIONS FROM THE HEALTH & SOCIAL CARE COMMITTEE: INQUIRY INTO NEW PSYCHOACTIVE SUBSTANCES

A Guide for Families, Friends and Carers

The Prime Minister s Challenge on Dementia. Lorraine Jackson Deputy Director: Domestic Dementia Policy Department of Health

Hearing aid dispenser approval process review Introduction Hearing aid dispenser data transfer... 6

British Association of Stroke Physicians Strategy 2017 to 2020

The audit is managed by the Royal College of Psychiatrists in partnership with:

PROCEDURE Mental Capacity Act. Number: E 0503 Date Published: 20 January 2016

National Chronic Kidney Disease Audit

A Framework for improving the experience of autistic adults using TEWV Services. MARCH 2018

National Cancer Programme: Living With and Beyond Cancer

Regional Strategic Plan

Management of AIDS/HIV Infected Healthcare Workers Policy

7th Annual Conference on Dementia & End of Life

Drug Misuse and Dependence Guidelines on Clinical Management

Dementia 2014: Opportunity for change England summary

Chairman s Report January 2016

Seldom Heard Voices Visual & Hearing Sensory Loss Prepared by: South Lincs Blind Society

OLDER PEOPLE WITH DUAL SENSORY LOSS: MEETING THEIR NEEDS. Nicola Venus-Balgobin

The National Council for Palliative Care Awards 2017 Judges Profiles

Flash Glucose Monitoring (Flash GM) Frequently asked questions (November 2018)

MJ Nomination Category: Innovation in Social Care Hull Multi Agency Safeguarding Hub (MASH) Humber NHS Foundation Trust

Mental Health Conference 2018

GOVERNING BODY MEETING in Public 22 February 2017 Agenda Item 3.4

in North East Lincolnshire Care Trust Plus Implementation Plan Executive Summary

ELR CCG Annual General Meeting. Tuesday 26 September 2017

The Welsh Government will ask people in health and social services to:

Enter & View WDP Havering Drug and alcohol dependency services 11 October 2016

Warrington Health Forum Terms of Reference

Participant Information Sheet

Getting ready to die. Palliative Care, End of Life Care and Bereavement

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

Scottish Parliament Region: North East Scotland. Case : Tayside NHS Board. Summary of Investigation

Transcription:

Response to the proposed advice for health and social care practitioners involved in looking after people in the last days of life Introduction i. Few conditions are as devastating as motor neurone disease (MND). It is rapidly progressive in the majority of cases, and is always fatal. People with MND will, in varying sequences and combinations, lose the ability to speak, swallow and use their limbs; the most common cause of death is respiratory failure. Most commonly the individual will remain mentally alert as they become trapped within a failing body, although some experience dementia or cognitive change. There are about 5,000 people living with MND in the UK. Half of people with the disease die within 14 months of diagnosis. There is no cure. i iv. The MND Association is the only national organisation supporting people affected by MND in England, Wales and Northern Ireland, with approximately 90 volunteer led branches and 3,000 volunteers. The MND Association s vision is of a World Free of MND. Until that time we will do everything we can to enable everyone with MND to receive the best care, achieve the highest quality of life possible and to die with dignity. End of life care therefore occupies a central position in the Association s work. In the last two years, we have undertaken a groundbreaking qualitative study of the attitudes of people living with MND to dying and the end of life, and conducted the largest ever survey of people with MND in the UK on these issues. We will shortly publish our first comprehensive package of advice and guidance on end of life issues to people with MND. We welcome the proposed advice and opportunity to comment on it. While we feel there is little in the proposed outcomes and guiding principles to object to in fact they usefully summarise what good care of people dying from MND should be able to expect - without strong implementation they will achieve little.. Whilst we do not advocate replacing the Liverpool Care Pathway with a similar tool, it should be remembered why the LCP was introduced and so widely used in England. Health and social care professionals not used to, or skilled in, caring for the dying need support to do so. While such professionals are unlikely to object to the guiding principles, having a document laying them out will not in itself help them to deliver good care in the last days and hours of life. If there is a sustained and well resourced programme of implementation, including education and training, standing behind the advice we would feel much more confident in the proposed approach.. If there is not, the standard of care available to dying people will deteriorate or, at best, not improve. We would like the Leadership Alliance to issue clear reassurance on this point, and set out the actions it will take as soon as possible. 1

v. Our response offers some observations on the proposals as a whole, then comment on more details aspects of them in response to specific questions in the consultation paper. Practical improvement of end of life care i. The discussion paper states that a programme of education and training will follow the initial exercise regarding advice and principles. This will be key: if it is sustained and properly resourced we would be optimistic about the prospects for improving care for dying people in England; if not, this may leave a vacuum in which standards will be allowed to deteriorate. i The NHS End of Life Care Programme, now defunct, showed the benefits of this approach with its End of Life Facilitators around the country, working on workforce development; now, workforce development in respect of end of life care appears to be much more haphazard. We hope that the Leadership Alliance will address this. We also note that the guidance does not extend to commissioners, and that there appear not to be any strong incentives for commissioners to commission high quality palliative, end of life and bereavement care. They are not the subject of any outcome or outcome indicator in the NHS Outcomes Framework or Outcomes Indicator Set, for instance. So while it is right that the guidance recommends that the needs of bereaved relatives are assessed and met, for instance, care professionals simply cannot do this if the appropriate services have not been commissioned. Under the new arrangements, clinical commissioning groups which decide to prioritise end of life care make it possible for health and social care professionals to improve practice; CCGs which do not chose to prioritise it make it difficult if not impossible for significant improvements to be made, and at worst, cause hard-won improvements arising from earlier work to be lost. Guidance, and preferably incentives, for commissioners must also follow. Guidance on end of life care i. We feel that the engagement document presents a fair general articulation of considerations around end of life care, but it is doubtful that it constitutes guidance in any practically useful sense. The format of the advice is not such that it could be readily and routinely referred to by clinicians and care professionals during their work. While the advice says it does not preclude the use of specific tools, it does not recommend any, or act as one itself, which leaves open the prospect of poor quality tools being used by inexpert clinicians in some locations, or guesses being made about the correct approach with no reference to any advice. The NHS End of Life Care Programme promoted three tools as representing good practice: the Gold Standards Framework, Preferred Priorities for Care and the Liverpool Care Pathway. The difficulties encountered with the latter appear to have prompted the Leadership Alliance to ditch the idea of usable tools or guidance entirely. It is not clear to us that this represents a positive step; rather, it seems to risk end of life care again becoming a lottery. 2

i We appreciate that experience with the Liverpool Care Pathway made clear the dangers of formulating guidance of this sort into a tool that can be readily and easily used: such a tool can also be readily and easily misused. This is why we advocate a strong programme of training and education: a focus on competence, and clear education about how tools should be used, and why they are written as they are, should foster high quality care. Guidance and tools can be a useful part of this, though they are not sufficient on their own as the Liverpool Care Pathway showed. We are concerned, however, that the current approach features neither education nor usefully accessible guidance. iv. Finally, we are concerned that the proposed approach features an unnecessary introduction of new terms and initiatives, most notably Personal Palliative Care Plans. Care planning and advance care planning already exist and perform the same function. New systems for holding and sharing palliative care plans are also almost certainly unnecessary: Electronic Palliative Care Co-ordination Systems already exist in some areas and address the same problem; much work has already been done to establish them. We strongly advise the Leadership Alliance to roll these initiatives out rather than attempt to reinvent them. 1. Do you agree with the proposed outcomes? If not, how can they be improved? We believe the proposed outcomes are sound; where we have concerns, they relate to how the outcomes will be achieved. 2. Are the guiding principles right and sufficient to achieve the particular outcomes? If not, how can they be improved? We believe the guiding principles are fair, and offer a few specific comments. Under Outcome B, point 4, it is not clear why the word monitor appears in inverted commas; it appears to be a perfectly fair word to describe the activity in question. Under Outcome B, point 6, it seems to be assumed that a person who can no longer swallow can also no longer express their wishes about artificial hydration, as no reference is made to seeking their views when possible. It may sometimes be the case that they cannot express their views, but it should not be assumed that this is not possible. 3. Do you agree that anyone who has a progressive life-limiting condition should be offered opportunity to develop, document, review and update a personalised palliative care plan, rather than a plan that focuses only on the last days of life? We have long advocated that people with MND should be offered the chance to receive palliative care and start planning for the future very soon after diagnosis. We already advocate that all people with MND have a care plan (not specifically for palliative care, although it can be said that all care for people with MND is, in the most neutral sense of the word, palliative), and that this should be developed in close collaboration with the person with MND, and regularly reviewed. Advance care 3

planning should be a key component of this exercise, but we are unconvinced of the need to reinvent it as a Personal Palliative Care Plan. In practice, professionals skilled in co-ordinating MND care encourage and work with people to plan and document their future wishes through the process of advance care planning, but might choose to use different language with the person with MND and their family (a popular phrase is planning for your future care ). 4. If you agree with the proposal to offer a personalised palliative care plan, do you agree with calling it a Personal Palliative Care Plan? If not, what should it be called? We would favour thorough and consistent promotion of existing initiatives and good practice, notably advance care planning. 5. If personalised palliative care plans are to be introduced, it raises a question of how and where this should be kept. If it is kept in the person s home, he/she would be able to look after it more easily. However, it may delay the ability of health and social care professionals (such as a doctor, nurse or ambulance staff) to take appropriate action on behalf of the person if the professional is not able to easily get hold of the information when needed. Do you have any ideas for how to find an answer to this practical question? This appears somewhat to be an attempt to reinvent the wheel: the Electronic Palliative Care Co-ordination Systems previously being rolled out by the NHS End of Life Care Programme provided a solution to this problem. 6. Do you have any other ideas or suggestions for how we can improve care for people in the last days of life? We note comment has not specifically been invited on the explanatory material intended for patients. Generally we regard this as sound. One place where we feel the language could be improved is under Outcome B, where it is stated that, you should be assessed regularly; it may be preferable to use the formulation your needs or similar. Recommendation 38 of Baroness Neuberger s report, listed in Annex A, is that condition-specific good practice guidance should be used to back up the individual end of life care plans that are now to be used in preference to the LCP. It is unclear whether this means condition-specific guidance on end of life issues though we infer that it does and where this guidance will come from. Will NICE or another public body be required to produce it? Should patient organisations take the issue into their own hands and produce it themselves? How will such guidance be promulgated? The MND Association is very willing to assist in the production of such guidance in respect of MND, but we would be grateful for some clarification of expectations on this issue. 4

For further information contact: Alice Fuller Campaigns and Development Manager MND Association David Niven House 10-15 Notre Dame Mews Northampton NN1 2BG Tel: 020 72508452 alice.fuller@mndassociation.org December 2013 5